Company / EPS (Diluted)
Repligen EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$0.86
FY2025
5-year range
-$0.46 / $3.24
FY2021-FY2025
Trend
+287.0%
vs FY2024
Sector context
#33 of 204
Health Care
What the data says
EPS (Diluted) changed +287% YoY in FY2025, a notable deviation from the 9-year average annual change of +44%.
Based on SEC 10-K filings.
0.86 in FY2025 with a 5-year CAGR of -5.0%. Top quartile in the Health Care sector.
Improved from $0.63 to $0.86 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -35.7%
- 5-Year CAGR
- -5.0%
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 204This company $0.86 Sector average -$0.98
▼
+187.8% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 287.0% year-over-year.
- Ranks #33 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2022.
- Lowest eps (diluted) in the period was in FY2024.
Company context
Key Data Points
- Negative profit margin: -18.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.86 | +287.0% |
| FY2024 | -$0.46 | -173.0% |
| FY2023 | $0.63 | -80.6% |
| FY2022 | $3.24 | +44.6% |
| FY2021 | $2.24 | +101.8% |
| FY2020 | $1.11 | +152.3% |
| FY2019 | $0.44 | +18.9% |
| FY2018 | $0.37 | +32.1% |
| FY2017 | $0.28 | +12.0% |
| FY2016 | $0.25 | -50.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026